Kevin Tang - Insider Trading & Ownership

Entity
Individual
Location
4747 Executive Drive, Suite 210, San Diego, CA
Summary
The estimated net worth of Kevin Tang is at least $103M dollars as of December 9, 2024. Kevin Tang is the Director of Aurinia Pharmaceuticals Inc. and owns shares of Aurinia Pharmaceuticals Inc. (AUPH) stock worth about $76.6M. Kevin Tang is the Chief Executive Officer, Director, 10%+ Owner of Odonate Therapeutics, Inc. and owns shares of Odonate Therapeutics, Inc. (ODTC) stock worth about $20M. Kevin Tang is the 10%+ Owner of Singular Genomics Systems, Inc. and owns shares of Singular Genomics Systems, Inc. (OMIC) stock worth about $6.4M. Kevin Tang is the Director, 10%+ Owner of Jounce Therapeutics, Inc. and owns shares of Jounce Therapeutics, Inc. stock worth about $18.5K.
All Insider Reports
All Insider Reports

Ownership of Kevin Tang

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AUPH Aurinia Pharmaceuticals Inc. Director $76.6M +$10.8M +16.4% Dec 5, 2024
ODTC Odonate Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner $20M Nov 17, 2021
OMIC Singular Genomics Systems, Inc. 10%+ Owner $6.4M +$1.81M +39.3% Sep 16, 2024
JNCE Jounce Therapeutics, Inc. Director, 10%+ Owner $18.5K May 3, 2023
RAIN Rain Oncology Inc. 10%+ Owner $0 Jan 26, 2024
TCRR TCR2 THERAPEUTICS INC. 10%+ Owner $0 Jun 1, 2023
APVO Aptevo Therapeutics Inc. Exit Filing Nov 23, 2021
LJPC LA JOLLA PHARMACEUTICAL CO Director, 10%+ Owner Aug 22, 2022

Insider Transactions Reported by Kevin Tang:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.